When multiple sizes, flavors, or formulations are offered, compare the details for each option to determine which best fits your needs
S3-Leitlinie Komplementrmedizin in der Behandlung von onkologischen PatientInnen Langversion Mai 2024, AWMF-Registernummer: 032/055OL Sato S, Namisaki T, Furukawa M, Saikawa S, Kawaratani H, Kaji K, Takaya H, Shimozato N, Sawada Y, Kitagawa K, Moriya K, Akahane T, Mitoro A, Hoki N, Ann T, Yoshiji H
Frontier Peptide Labs does not provide dosing, administration, human-use, veterinary-use, diagnostic, cosmetic, or therapeutic guidance
However, it is not MHRA-approved and cannot be used for human consumption, therapeutic use or medical application